CA2414352A1 - Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies - Google Patents
Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies Download PDFInfo
- Publication number
- CA2414352A1 CA2414352A1 CA002414352A CA2414352A CA2414352A1 CA 2414352 A1 CA2414352 A1 CA 2414352A1 CA 002414352 A CA002414352 A CA 002414352A CA 2414352 A CA2414352 A CA 2414352A CA 2414352 A1 CA2414352 A1 CA 2414352A1
- Authority
- CA
- Canada
- Prior art keywords
- treating
- neuropathies
- peripheral
- derivative
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21506500P | 2000-06-30 | 2000-06-30 | |
US60/215,065 | 2000-06-30 | ||
US21902900P | 2000-07-18 | 2000-07-18 | |
US60/219,029 | 2000-07-18 | ||
PCT/US2001/041202 WO2002002118A1 (en) | 2000-06-30 | 2001-06-29 | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2414352A1 true CA2414352A1 (en) | 2002-01-10 |
Family
ID=26909649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002414352A Abandoned CA2414352A1 (en) | 2000-06-30 | 2001-06-29 | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1303279A1 (ja) |
JP (1) | JP2004511433A (ja) |
KR (1) | KR20030047907A (ja) |
CN (1) | CN1440287A (ja) |
AU (1) | AU2001279275A1 (ja) |
BR (1) | BR0112100A (ja) |
CA (1) | CA2414352A1 (ja) |
HU (1) | HUP0301451A3 (ja) |
IL (1) | IL153426A0 (ja) |
MX (1) | MXPA03000033A (ja) |
NZ (1) | NZ523108A (ja) |
PL (1) | PL365565A1 (ja) |
WO (1) | WO2002002118A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0020588D0 (en) * | 2000-08-21 | 2000-10-11 | Pfizer Ltd | Treatment of wounds |
US8133903B2 (en) | 2003-10-21 | 2012-03-13 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases |
EP1605925A1 (en) * | 2003-03-17 | 2005-12-21 | Pfizer Products Inc. | Treatment of type 1 diabetes with pde5 inhibitors |
FR2877013A1 (fr) * | 2004-10-27 | 2006-04-28 | Assist Publ Hopitaux De Paris | Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez |
WO2006074443A2 (en) * | 2005-01-07 | 2006-07-13 | The Johns Hopkins University | Pde5 inhibitor compositions and methods for immunotherapy |
MX2017016930A (es) * | 2017-12-19 | 2019-06-20 | Malesil Research & Tech Llc | Uso del maleato de sildenafil en el tratamiento de ulceras de pie diabetico. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043252A (en) * | 1997-05-05 | 2000-03-28 | Icos Corporation | Carboline derivatives |
US6075028A (en) * | 1999-09-23 | 2000-06-13 | Graham; Richard | Method of treating Tourette's syndrome and related CNS disorders |
-
2001
- 2001-06-29 IL IL15342601A patent/IL153426A0/xx unknown
- 2001-06-29 PL PL01365565A patent/PL365565A1/xx not_active Application Discontinuation
- 2001-06-29 MX MXPA03000033A patent/MXPA03000033A/es unknown
- 2001-06-29 WO PCT/US2001/041202 patent/WO2002002118A1/en not_active Application Discontinuation
- 2001-06-29 CA CA002414352A patent/CA2414352A1/en not_active Abandoned
- 2001-06-29 KR KR1020027017948A patent/KR20030047907A/ko not_active Application Discontinuation
- 2001-06-29 JP JP2002506740A patent/JP2004511433A/ja active Pending
- 2001-06-29 CN CN01812103A patent/CN1440287A/zh active Pending
- 2001-06-29 BR BR0112100-6A patent/BR0112100A/pt not_active IP Right Cessation
- 2001-06-29 EP EP01957540A patent/EP1303279A1/en not_active Withdrawn
- 2001-06-29 HU HU0301451A patent/HUP0301451A3/hu unknown
- 2001-06-29 AU AU2001279275A patent/AU2001279275A1/en not_active Abandoned
- 2001-06-29 NZ NZ523108A patent/NZ523108A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002002118A1 (en) | 2002-01-10 |
AU2001279275A1 (en) | 2002-01-14 |
EP1303279A1 (en) | 2003-04-23 |
HUP0301451A2 (hu) | 2003-09-29 |
KR20030047907A (ko) | 2003-06-18 |
NZ523108A (en) | 2005-04-29 |
JP2004511433A (ja) | 2004-04-15 |
HUP0301451A3 (en) | 2004-10-28 |
IL153426A0 (en) | 2003-07-06 |
MXPA03000033A (es) | 2003-09-25 |
PL365565A1 (en) | 2005-01-10 |
BR0112100A (pt) | 2003-05-20 |
CN1440287A (zh) | 2003-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101287457B (zh) | Treprostinil用于治疗神经性糖尿病的足部溃疡的用途 | |
JP2002506023A (ja) | 粘膜炎の処置および予防のための方法および組成物 | |
KR20070032619A (ko) | 폐동맥 고혈압의 치료를 위한 일로프로스트의 복합 치료제 | |
JP2002523370A5 (ja) | ||
JP2002528502A5 (ja) | ||
CA2559239A1 (en) | Use of simethicone and sodium picosulphate in constipated patients suffering from bloated feeling and gas discomfort during the night | |
CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
CA2414352A1 (en) | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies | |
JP2005525329A5 (ja) | ||
RU2543635C2 (ru) | Способ и фармацевтические композиции для лечения постпрандиальной гипергликемии диабета ii типа введением через слизистую ротовой полости | |
JP2002534477A (ja) | メラガトランの新規使用 | |
JP2005501068A (ja) | 特に眼科分野における適用のための外傷および損傷の治癒および/または修復のための治療に適したアミノ酸組成物 | |
JPH01261334A (ja) | アンギオテンシン転換酵素阻害剤を有効成分とした医療用調剤及びその製造方法 | |
AU2002220960B2 (en) | Regeneration of blood vessels | |
CA2493208A1 (en) | Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure | |
CA2474430A1 (en) | A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction | |
WO2004028457A3 (en) | PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY | |
CA2590224A1 (en) | Method for reduction, stabilization and prevention of rupture of lipid rich plaque | |
CA2474703A1 (en) | Therapeutic agent of glaucoma comprising bunazosin and prostaglandins | |
AU2002220960A1 (en) | Regeneration of blood vessels | |
MD1568G2 (ro) | Metodă de tratament al bolii arşilor în perioada şocului combustional | |
RU2003106417A (ru) | Применение комбинации витаминов для лечения первичных головных болей | |
JPH0959149A (ja) | 消炎鎮痛組成物 | |
CN117243947A (zh) | 瑞香素及包含其的组合在制备糖尿病并发症药物中的应用 | |
ATE284696T1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |